Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors

We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2006-11, Vol.49 (24), p.6950-6953
Hauptverfasser: Ikegashira, Kazutaka, Oka, Takahiro, Hirashima, Shintaro, Noji, Satoru, Yamanaka, Hiroshi, Hara, Yoshinori, Adachi, Tsuyoshi, Tsuruha, Jun-Ichiro, Doi, Satoki, Hase, Yasunori, Noguchi, Toru, Ando, Izuru, Ogura, Naoki, Ikeda, Satoru, Hashimoto, Hiromasa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6953
container_issue 24
container_start_page 6950
container_title Journal of medicinal chemistry
container_volume 49
creator Ikegashira, Kazutaka
Oka, Takahiro
Hirashima, Shintaro
Noji, Satoru
Yamanaka, Hiroshi
Hara, Yoshinori
Adachi, Tsuyoshi
Tsuruha, Jun-Ichiro
Doi, Satoki
Hase, Yasunori
Noguchi, Toru
Ando, Izuru
Ogura, Naoki
Ikeda, Satoru
Hashimoto, Hiromasa
description We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.
doi_str_mv 10.1021/jm0610245
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68186795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19735453</sourcerecordid><originalsourceid>FETCH-LOGICAL-a478t-eb852afb06b53a52915f51f71e0506957d8bb520aa343cc1dd64491264c29f243</originalsourceid><addsrcrecordid>eNqF0c9v0zAUB3ALMbEyOPAPIF9A4hDmn4lzXDvKJlVj2kqvluM4wiWJO78EEf56PLVaL5N28tPzx09--iL0gZKvlDB6vu1IngohX6EZlYxkQhHxGs0IYSxjOeOn6C3AlhDCKeNv0CktKJNMFDP079KDDX9cnHBo8CL0TYidGXzoTdtOjw0YovG9q_HapcpOtvU29btdGPsasAF8GwbXD_jK7dLDwQNe4I2PI-CbeznHdzcXSbRT56IBh6_7X77yQ4jwDp00pgX3_nCeoZ_Lb-vFVbb68f16cbHKjCjUkLlKSWaaiuSV5EaykspG0qagjkiSl7KoVVWlpY3hgltL6zoXoqQsF5aVDRP8DH3ez93F8DA6GHSXdnZta3oXRtC5oiovSvkipGXBpZA8wS97aGMAiK7Ru-g7EydNiX5MRD8lkuzHw9Cx6lx9lIcIEvh0AAasaZtoeuvh6BRnUqkyuWzvPAzu79O9ib91XvBC6vXtvd4sV5fz5d1Gz49zjQW9DWNMicIzH_wPQeCt2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19735453</pqid></control><display><type>article</type><title>Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Ikegashira, Kazutaka ; Oka, Takahiro ; Hirashima, Shintaro ; Noji, Satoru ; Yamanaka, Hiroshi ; Hara, Yoshinori ; Adachi, Tsuyoshi ; Tsuruha, Jun-Ichiro ; Doi, Satoki ; Hase, Yasunori ; Noguchi, Toru ; Ando, Izuru ; Ogura, Naoki ; Ikeda, Satoru ; Hashimoto, Hiromasa</creator><creatorcontrib>Ikegashira, Kazutaka ; Oka, Takahiro ; Hirashima, Shintaro ; Noji, Satoru ; Yamanaka, Hiroshi ; Hara, Yoshinori ; Adachi, Tsuyoshi ; Tsuruha, Jun-Ichiro ; Doi, Satoki ; Hase, Yasunori ; Noguchi, Toru ; Ando, Izuru ; Ogura, Naoki ; Ikeda, Satoru ; Hashimoto, Hiromasa</creatorcontrib><description>We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm0610245</identifier><identifier>PMID: 17125247</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - chemical synthesis ; Antiviral Agents - chemistry ; Antiviral Agents - pharmacology ; Benzodiazepines - chemical synthesis ; Benzodiazepines - chemistry ; Benzodiazepines - pharmacology ; Biological and medical sciences ; Crystallography, X-Ray ; Hepacivirus - enzymology ; Hepacivirus - genetics ; Hepatitis C virus ; Heterocyclic Compounds, 4 or More Rings - chemical synthesis ; Heterocyclic Compounds, 4 or More Rings - chemistry ; Heterocyclic Compounds, 4 or More Rings - pharmacology ; Humans ; Indoles - chemical synthesis ; Indoles - chemistry ; Indoles - pharmacology ; Medical sciences ; Models, Molecular ; Molecular Conformation ; Pharmacology. Drug treatments ; Replicon ; RNA, Viral - genetics ; Serum Albumin ; Structure-Activity Relationship ; Viral Nonstructural Proteins - antagonists &amp; inhibitors ; Viral Nonstructural Proteins - chemistry</subject><ispartof>Journal of medicinal chemistry, 2006-11, Vol.49 (24), p.6950-6953</ispartof><rights>Copyright © 2006 American Chemical Society</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a478t-eb852afb06b53a52915f51f71e0506957d8bb520aa343cc1dd64491264c29f243</citedby><cites>FETCH-LOGICAL-a478t-eb852afb06b53a52915f51f71e0506957d8bb520aa343cc1dd64491264c29f243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm0610245$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm0610245$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18325889$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17125247$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ikegashira, Kazutaka</creatorcontrib><creatorcontrib>Oka, Takahiro</creatorcontrib><creatorcontrib>Hirashima, Shintaro</creatorcontrib><creatorcontrib>Noji, Satoru</creatorcontrib><creatorcontrib>Yamanaka, Hiroshi</creatorcontrib><creatorcontrib>Hara, Yoshinori</creatorcontrib><creatorcontrib>Adachi, Tsuyoshi</creatorcontrib><creatorcontrib>Tsuruha, Jun-Ichiro</creatorcontrib><creatorcontrib>Doi, Satoki</creatorcontrib><creatorcontrib>Hase, Yasunori</creatorcontrib><creatorcontrib>Noguchi, Toru</creatorcontrib><creatorcontrib>Ando, Izuru</creatorcontrib><creatorcontrib>Ogura, Naoki</creatorcontrib><creatorcontrib>Ikeda, Satoru</creatorcontrib><creatorcontrib>Hashimoto, Hiromasa</creatorcontrib><title>Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - chemistry</subject><subject>Antiviral Agents - pharmacology</subject><subject>Benzodiazepines - chemical synthesis</subject><subject>Benzodiazepines - chemistry</subject><subject>Benzodiazepines - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Crystallography, X-Ray</subject><subject>Hepacivirus - enzymology</subject><subject>Hepacivirus - genetics</subject><subject>Hepatitis C virus</subject><subject>Heterocyclic Compounds, 4 or More Rings - chemical synthesis</subject><subject>Heterocyclic Compounds, 4 or More Rings - chemistry</subject><subject>Heterocyclic Compounds, 4 or More Rings - pharmacology</subject><subject>Humans</subject><subject>Indoles - chemical synthesis</subject><subject>Indoles - chemistry</subject><subject>Indoles - pharmacology</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Pharmacology. Drug treatments</subject><subject>Replicon</subject><subject>RNA, Viral - genetics</subject><subject>Serum Albumin</subject><subject>Structure-Activity Relationship</subject><subject>Viral Nonstructural Proteins - antagonists &amp; inhibitors</subject><subject>Viral Nonstructural Proteins - chemistry</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c9v0zAUB3ALMbEyOPAPIF9A4hDmn4lzXDvKJlVj2kqvluM4wiWJO78EEf56PLVaL5N28tPzx09--iL0gZKvlDB6vu1IngohX6EZlYxkQhHxGs0IYSxjOeOn6C3AlhDCKeNv0CktKJNMFDP079KDDX9cnHBo8CL0TYidGXzoTdtOjw0YovG9q_HapcpOtvU29btdGPsasAF8GwbXD_jK7dLDwQNe4I2PI-CbeznHdzcXSbRT56IBh6_7X77yQ4jwDp00pgX3_nCeoZ_Lb-vFVbb68f16cbHKjCjUkLlKSWaaiuSV5EaykspG0qagjkiSl7KoVVWlpY3hgltL6zoXoqQsF5aVDRP8DH3ez93F8DA6GHSXdnZta3oXRtC5oiovSvkipGXBpZA8wS97aGMAiK7Ru-g7EydNiX5MRD8lkuzHw9Cx6lx9lIcIEvh0AAasaZtoeuvh6BRnUqkyuWzvPAzu79O9ib91XvBC6vXtvd4sV5fz5d1Gz49zjQW9DWNMicIzH_wPQeCt2A</recordid><startdate>20061130</startdate><enddate>20061130</enddate><creator>Ikegashira, Kazutaka</creator><creator>Oka, Takahiro</creator><creator>Hirashima, Shintaro</creator><creator>Noji, Satoru</creator><creator>Yamanaka, Hiroshi</creator><creator>Hara, Yoshinori</creator><creator>Adachi, Tsuyoshi</creator><creator>Tsuruha, Jun-Ichiro</creator><creator>Doi, Satoki</creator><creator>Hase, Yasunori</creator><creator>Noguchi, Toru</creator><creator>Ando, Izuru</creator><creator>Ogura, Naoki</creator><creator>Ikeda, Satoru</creator><creator>Hashimoto, Hiromasa</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20061130</creationdate><title>Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</title><author>Ikegashira, Kazutaka ; Oka, Takahiro ; Hirashima, Shintaro ; Noji, Satoru ; Yamanaka, Hiroshi ; Hara, Yoshinori ; Adachi, Tsuyoshi ; Tsuruha, Jun-Ichiro ; Doi, Satoki ; Hase, Yasunori ; Noguchi, Toru ; Ando, Izuru ; Ogura, Naoki ; Ikeda, Satoru ; Hashimoto, Hiromasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a478t-eb852afb06b53a52915f51f71e0506957d8bb520aa343cc1dd64491264c29f243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - chemistry</topic><topic>Antiviral Agents - pharmacology</topic><topic>Benzodiazepines - chemical synthesis</topic><topic>Benzodiazepines - chemistry</topic><topic>Benzodiazepines - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Crystallography, X-Ray</topic><topic>Hepacivirus - enzymology</topic><topic>Hepacivirus - genetics</topic><topic>Hepatitis C virus</topic><topic>Heterocyclic Compounds, 4 or More Rings - chemical synthesis</topic><topic>Heterocyclic Compounds, 4 or More Rings - chemistry</topic><topic>Heterocyclic Compounds, 4 or More Rings - pharmacology</topic><topic>Humans</topic><topic>Indoles - chemical synthesis</topic><topic>Indoles - chemistry</topic><topic>Indoles - pharmacology</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Pharmacology. Drug treatments</topic><topic>Replicon</topic><topic>RNA, Viral - genetics</topic><topic>Serum Albumin</topic><topic>Structure-Activity Relationship</topic><topic>Viral Nonstructural Proteins - antagonists &amp; inhibitors</topic><topic>Viral Nonstructural Proteins - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ikegashira, Kazutaka</creatorcontrib><creatorcontrib>Oka, Takahiro</creatorcontrib><creatorcontrib>Hirashima, Shintaro</creatorcontrib><creatorcontrib>Noji, Satoru</creatorcontrib><creatorcontrib>Yamanaka, Hiroshi</creatorcontrib><creatorcontrib>Hara, Yoshinori</creatorcontrib><creatorcontrib>Adachi, Tsuyoshi</creatorcontrib><creatorcontrib>Tsuruha, Jun-Ichiro</creatorcontrib><creatorcontrib>Doi, Satoki</creatorcontrib><creatorcontrib>Hase, Yasunori</creatorcontrib><creatorcontrib>Noguchi, Toru</creatorcontrib><creatorcontrib>Ando, Izuru</creatorcontrib><creatorcontrib>Ogura, Naoki</creatorcontrib><creatorcontrib>Ikeda, Satoru</creatorcontrib><creatorcontrib>Hashimoto, Hiromasa</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ikegashira, Kazutaka</au><au>Oka, Takahiro</au><au>Hirashima, Shintaro</au><au>Noji, Satoru</au><au>Yamanaka, Hiroshi</au><au>Hara, Yoshinori</au><au>Adachi, Tsuyoshi</au><au>Tsuruha, Jun-Ichiro</au><au>Doi, Satoki</au><au>Hase, Yasunori</au><au>Noguchi, Toru</au><au>Ando, Izuru</au><au>Ogura, Naoki</au><au>Ikeda, Satoru</au><au>Hashimoto, Hiromasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2006-11-30</date><risdate>2006</risdate><volume>49</volume><issue>24</issue><spage>6950</spage><epage>6953</epage><pages>6950-6953</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>17125247</pmid><doi>10.1021/jm0610245</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2006-11, Vol.49 (24), p.6950-6953
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_68186795
source MEDLINE; American Chemical Society Journals
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Antiviral Agents - chemical synthesis
Antiviral Agents - chemistry
Antiviral Agents - pharmacology
Benzodiazepines - chemical synthesis
Benzodiazepines - chemistry
Benzodiazepines - pharmacology
Biological and medical sciences
Crystallography, X-Ray
Hepacivirus - enzymology
Hepacivirus - genetics
Hepatitis C virus
Heterocyclic Compounds, 4 or More Rings - chemical synthesis
Heterocyclic Compounds, 4 or More Rings - chemistry
Heterocyclic Compounds, 4 or More Rings - pharmacology
Humans
Indoles - chemical synthesis
Indoles - chemistry
Indoles - pharmacology
Medical sciences
Models, Molecular
Molecular Conformation
Pharmacology. Drug treatments
Replicon
RNA, Viral - genetics
Serum Albumin
Structure-Activity Relationship
Viral Nonstructural Proteins - antagonists & inhibitors
Viral Nonstructural Proteins - chemistry
title Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T17%3A19%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20of%20Conformationally%20Constrained%20Tetracyclic%20Compounds%20as%20Potent%20Hepatitis%20C%20Virus%20NS5B%20RNA%20Polymerase%20Inhibitors&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Ikegashira,%20Kazutaka&rft.date=2006-11-30&rft.volume=49&rft.issue=24&rft.spage=6950&rft.epage=6953&rft.pages=6950-6953&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm0610245&rft_dat=%3Cproquest_cross%3E19735453%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19735453&rft_id=info:pmid/17125247&rfr_iscdi=true